Literature DB >> 10419604

Denaturation of type II collagen in articular cartilage in experimental murine arthritis. Evidence for collagen degradation in both reversible and irreversible cartilage damage.

R Stoop1, P M van der Kraan, P Buma, A P Hollander, A R Poole, W B van den Berg.   

Abstract

Degradation of type II collagen is thought to be a key step in the destruction of articular cartilage in patients with rheumatoid arthritis or osteoarthritis. The aim of this study was to investigate whether type II collagen degradation is associated with cartilage destruction. Type II collagen degradation was studied in two murine arthritis models, zymosan-induced arthritis (ZIA), which develops reversible articular cartilage damage based on proteoglycan analysis, and antigen-induced arthritis (AIA), in which there is irreversible damage to the cartilage. Type II collagen degradation was assayed immunohistochemically using the COL2-3/4m antibody which recognizes denatured type II collagen, such as is produced by collagenase cleavage. In both models, degradation of type II collagen was observed in the non-calcified articular cartilage of arthritic but not of control knees. In the patella-femoral compartment, collagen denaturation started to increase on day 3 (ZIA) and day 7 (AIA) and remained high on day 14. In contrast, in the tibia-femoral compartment, type II collagen breakdown was not increased before 14 days in either model. By 28 days, collagen denaturation was strongly reduced in the patella-femoral compartment in the ZIA model, but persisted in the tibia-femoral compartment in both models. In conclusion, increased type II collagen degradation was found in articular cartilage of both ZIA and AIA animals. Since ZIA does not develop irreversible cartilage destruction, this indicates that cartilage may have the ability to withstand a limited degree of type II collagen degradation without developing irreversible damage. Copyright 1999 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10419604     DOI: 10.1002/(SICI)1096-9896(199907)188:3<329::AID-PATH371>3.0.CO;2-B

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  14 in total

1.  Expression of transforming growth factor-beta (TGFbeta) and the TGFbeta signalling molecule SMAD-2P in spontaneous and instability-induced osteoarthritis: role in cartilage degradation, chondrogenesis and osteophyte formation.

Authors:  E N Blaney Davidson; E L Vitters; P M van der Kraan; W B van den Berg
Journal:  Ann Rheum Dis       Date:  2006-01-26       Impact factor: 19.103

Review 2.  An overview of the role of lipid peroxidation-derived 4-hydroxynonenal in osteoarthritis.

Authors:  Jamilah Abusarah; Mireille Bentz; Houda Benabdoune; Patricia Elsa Rondon; Qin Shi; Julio C Fernandes; Hassan Fahmi; Mohamed Benderdour
Journal:  Inflamm Res       Date:  2017-04-26       Impact factor: 4.575

3.  Time between anterior cruciate ligament injury and reconstruction and cartilage metabolism six-months following reconstruction.

Authors:  Hope C Davis; Jeffery T Spang; Richard F Loeser; Staffan Larsson; Veronica Ulici; J Troy Blackburn; R Alexander Creighton; Ganesh M Kamath; Joanne M Jordan; Stephen W Marshall; Brian Pietrosimone
Journal:  Knee       Date:  2018-03-07       Impact factor: 2.199

4.  Lifelong voluntary joint loading increases osteoarthritis in mice housing a deletion mutation in type II procollagen gene, and slightly also in non-transgenic mice.

Authors:  T Lapveteläinen; M M Hyttinen; A-M Säämänen; T Långsjö; J Sahlman; S Felszeghy; E Vuorio; H J Helminen
Journal:  Ann Rheum Dis       Date:  2002-09       Impact factor: 19.103

5.  Type II and VI collagen in nasal and articular cartilage and the effect of IL-1alpha on the distribution of these collagens.

Authors:  I D C Jansen; A P Hollander; D J Buttle; V Everts
Journal:  J Mol Histol       Date:  2010-03-06       Impact factor: 2.611

Review 6.  Targeting collagen for diagnostic imaging and therapeutic delivery.

Authors:  Hendra Wahyudi; Amanda A Reynolds; Yang Li; Shawn C Owen; S Michael Yu
Journal:  J Control Release       Date:  2016-01-07       Impact factor: 9.776

Review 7.  Which elements are involved in reversible and irreversible cartilage degradation in osteoarthritis?

Authors:  Anne-Christine Bay-Jensen; Suzi Hoegh-Madsen; Erik Dam; Kim Henriksen; Bodil Cecillie Sondergaard; Philippe Pastoureau; Per Qvist; Morten A Karsdal
Journal:  Rheumatol Int       Date:  2009-10-09       Impact factor: 2.631

8.  Blocking aggrecanase cleavage in the aggrecan interglobular domain abrogates cartilage erosion and promotes cartilage repair.

Authors:  Christopher B Little; Clare T Meeker; Suzanne B Golub; Kate E Lawlor; Pamela J Farmer; Susan M Smith; Amanda J Fosang
Journal:  J Clin Invest       Date:  2007-05-17       Impact factor: 14.808

Review 9.  Biochemical markers of ongoing joint damage in rheumatoid arthritis--current and future applications, limitations and opportunities.

Authors:  Morten A Karsdal; Thasia Woodworth; Kim Henriksen; Walter P Maksymowych; Harry Genant; Philippe Vergnaud; Claus Christiansen; Tanja Schubert; Per Qvist; Georg Schett; Adam Platt; Anne-Christine Bay-Jensen
Journal:  Arthritis Res Ther       Date:  2011-04-28       Impact factor: 5.156

10.  Collagen biomarkers for arthritis applications.

Authors:  James D Birmingham; Vladimir Vilim; Virginia B Kraus
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.